期刊
JOURNAL OF BIOMOLECULAR SCREENING
卷 18, 期 8, 页码 879-889出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1087057113489731
关键词
kynurenine; 3-hydroxykynurenine; kynurenine 3-monooxygenase; LC/MS/MS; microglia; human PBMCs
资金
- CHDI Foundation
Kynurenine monooxygenase (KMO) catalyzes the conversion of kynurenine to 3-hydroxykynurenine. Modulation of KMO activity has been implicated in several neurodegenerative diseases, including Huntington disease. Our goal is to develop potent and selective small-molecule KMO inhibitors with suitable pharmacokinetic characteristics for in vivo proof-of-concept studies and subsequent clinical development. We developed a comprehensive panel of biochemical and cell-based assays that use liquid chromatography/tandem mass spectrometry to quantify unlabeled kynurenine and 3-hydroxykynurenine. We describe assays to measure KMO inhibition in cell and tissue extracts, as well as cellular assays including heterologous cell lines and primary rat microglia and human peripheral blood mononuclear cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据